Free tool
LHCVX and PRHSX: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between LHCVX and PRHSX
47% of their top holdings overlap by weight, with 10 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that PRHSX holds far more positions (279 vs 61), so it is broader beyond the top names.
| Holding | % of LHCVX | % of PRHSX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 14.28% |
| UnitedHealth Group Inc | 5.39% | 5.99% |
| Johnson & Johnson | 4.96% | 6.63% |
| Natera Inc | 3.60% | 1.44% |
| Gilead Sciences Inc | 3.53% | 2.82% |
| CVS Health Corp | 3.33% | 0.94% |
| Guardant Health Inc | 2.61% | 1.23% |
| Thermo Fisher Scientific Inc | 2.31% | 2.52% |
| Vertex Pharmaceuticals Inc | 2.24% | 2.28% |
| Protagonist Therapeutics Inc | 1.44% | 0.85% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized